Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

LevelJump Healthcare levels-up with strong 2024 financial results

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| June 23, 2025

{{labelSign}}  Favorites
{{errorMessage}}

(AI generated stock image.)
  • LevelJump Healthcare (TSXV:JUMP) announced its financial results for 2024, offering up some robust revenue growth and decent momentum for 2025
  • The company reported revenues of C$17.7 million for the full year 2024, marking a 41 per cent increase compared to C$12.6 million in 2023
  • The company signed an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary
  • LevelJump Healthcare stock (TSXV: JUMP) last traded at $0.05

LevelJump Healthcare (TSXV:JUMP), a leading provider of teleradiology and diagnostic imaging services in Canada, has announced its audited financial results for the year ended December 31st, 2024, offering up some robust revenue growth and decent momentum for 2025.

Financial highlights

The company reported revenues of C$17.7 million for the full year 2024, marking a 41 per cent increase compared to C$12.6 million in 2023. This growth was driven primarily by the performance of its wholly owned subsidiary, Canadian Teleradiology Services, Inc., which posted an EBITDA of C$3.35 million for the year.

In Q42024, LevelJump generated C$4.8 million in revenue and achieved a net profit of C$1.95 million, contributing to a full-year net profit of C$1.2 million. EBITDA for Q4 stood at C$395,936, with a total annual EBITDA of C$1.55 million.

Operational momentum and expansion

Following the year-end, LevelJump announced a significant expansion initiative. The company has signed an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary. This acquisition is expected to close by the end of July 2025, further strengthening LevelJump’s footprint in Western Canada.

Leadership insights

“2024 was a transformative year for our Company, marked by significant growth, particularly within our clinic operations,” the company’s CEO, Mitch Geisler, said in a news release. “Our year-over-year revenue increased by more than 40%, and we achieved strong EBITDA performance. We are now interpreting imaging scans for approximately 200,000 patients annually across all operations. Our focus remains on driving organic growth and advancing our long-term vision for continued expansion.”

About LevelJump Healthcare

LevelJump Healthcare Corp. provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres.

LevelJump Healthcare stock (TSXV: JUMP) last traded at $0.05, but has lost 47.37 per cent since the beginning of the year.

Join the discussion: Find out what everybody’s saying about this stock on the LevelJump Healthcare Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}